PTPRC and neoplasm: Each ROI was segmented into CD45+ immune fractions and PanCK+ tumor fractions by manually selecting CD45 and PanCK fluorescence thresholds that visually maximized the individual cell types, allowing for the evaluation of 71 protein targets expressed within each individual fraction (targets are listed in Supplementary Table S3).